Lunai Bioworks (NASDAQ: LNAI), an AI-powered drug discovery and biodefense company, has announced a major scientific ...
Once thought to be a flaw in the system, new research suggests that CD4 T cells may actually hold the key to maintaining a ...
New data provide key mechanistic insights into how TG4050 induces and sustains potent, CD8+ T cell responses in operable HNSCC[*] patients Comprehensive immunogenicity data demonstrate TG4050’s ...
Myongji Hospitals Immune Cell Therapy Shrinks Tumors, Boosts Survival Combination with anticancer drugs reduces tumors in ...
Inflammatory arthritis resulting from immune checkpoint inhibitor use is immunologically unique and likely driven by T cells ...
A recent study published in Nature on October 22, 2025 has revealed an unexpected benefit of mRNA vaccination, suggesting ...
In 2006 immunologist and 2025 Nobel prize winner Shimon Sakaguchi co-wrote an article in Scientific American that now feels prophetic. In the story, entitled “Peacekeepers of the Immune System,” ...
Cabaletta Bio’s CAR-T cell therapy has eliminated the overreactive B cells of two patients with an autoimmune disease without preconditioning chemotherapy, pleasing investors and analysts while ...
Major surgery is associated with transient suppression of T-cell immunity, increasing susceptibility to severe infections. This study identifies a previously unrecognized mechanism that drives ...
Immunotherapy is currently effective in less than half of patients with solid tumors, and most responders develop secondary progression. High infiltration of the tumor microenvironment (TME) with CD8 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback